Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederik Giesel

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Nuclear Medicine and Molecular Imaging|September 22, 2025
Exploring the Diagnostic and Theranostic Role of FAPI PET in Soft Tissue Sarcoma: A Systematic ReviewMarwah Abdulrahman, Frederik Giesel, Andrew M Scott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Design and Development of <sup>99m</sup>Tc-Labeled FAPI Tracers for SPECT Imaging and <sup>188</sup>Re TherapyThomas Lindner, Annette Altmann, Susanne Krämer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
A Tumor-Imaging Method Targeting Cancer-Associated FibroblastsAnastasia Loktev, Thomas Lindner, Walter Mier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor RetentionAnastasia Loktev, Thomas Lindner, Eva-Maria Burger, et al.
EJNMMI Radiopharmacy and Chemistry|August 21, 2021
<sup>18</sup>F-labeled tracers targeting fibroblast activation proteinThomas Lindner, Annette Altmann, Frederik Giesel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2020
Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastomaPaul Windisch, Manuel Röhrich, Sebastian Regnery, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 23, 2026
Clinical Evaluation of a New Automated Bridge Assay for the Detection of Thyroid-Stimulating Hormone Receptor AutoantibodiesPatricia Schott-Ohly, Samer Albeiruty, Mareike Muchalla, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 25, 2022
BRAFV600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid CancerMargret Ehlers, Mathias Schmidt, Katalin Mattes-Gyorgy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2021
Fibroblast activation protein targeted therapy using [<sup>177</sup>Lu]FAPI-46 compared with [<sup>225</sup>Ac]FAPI-46 in a pancreatic cancer modelYuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, et al.
Radiology|May 23, 2018
Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate CancerSonya Youngju Park, Claudia Zacharias, Caitlyn Harrison, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Nuclear Medicine and Molecular Imaging|September 22, 2025
Exploring the Diagnostic and Theranostic Role of FAPI PET in Soft Tissue Sarcoma: A Systematic ReviewMarwah Abdulrahman, Frederik Giesel, Andrew M Scott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Design and Development of <sup>99m</sup>Tc-Labeled FAPI Tracers for SPECT Imaging and <sup>188</sup>Re TherapyThomas Lindner, Annette Altmann, Susanne Krämer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
A Tumor-Imaging Method Targeting Cancer-Associated FibroblastsAnastasia Loktev, Thomas Lindner, Walter Mier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor RetentionAnastasia Loktev, Thomas Lindner, Eva-Maria Burger, et al.
EJNMMI Radiopharmacy and Chemistry|August 21, 2021
<sup>18</sup>F-labeled tracers targeting fibroblast activation proteinThomas Lindner, Annette Altmann, Frederik Giesel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2020
Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastomaPaul Windisch, Manuel Röhrich, Sebastian Regnery, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 23, 2026
Clinical Evaluation of a New Automated Bridge Assay for the Detection of Thyroid-Stimulating Hormone Receptor AutoantibodiesPatricia Schott-Ohly, Samer Albeiruty, Mareike Muchalla, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 25, 2022
BRAFV600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid CancerMargret Ehlers, Mathias Schmidt, Katalin Mattes-Gyorgy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2021
Fibroblast activation protein targeted therapy using [<sup>177</sup>Lu]FAPI-46 compared with [<sup>225</sup>Ac]FAPI-46 in a pancreatic cancer modelYuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, et al.
Radiology|May 23, 2018
Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate CancerSonya Youngju Park, Claudia Zacharias, Caitlyn Harrison, et al.
Pageof 7